Helixbind, Inc.
Publicly observedBoxborough, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Boxborough | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Helixbind, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | C37HLWKKAH69 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant16 Jul 2026Publicly observed
NIH SBIR/STTR award: Automated system for the direct from blood characterization of bloodstream infections
USD 1,029,859.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 Jul 2024Publicly observed
NIH SBIR/STTR award: An automated culture-free system for the identification of bloodstream infections direct from blood
USD 1,019,702.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant8 Jul 2024Publicly observed
NIH SBIR/STTR award: An automated culture-free system for the identification of bloodstream infections direct from blood
USD 1,027,841.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant2 Apr 2024Publicly observed
NIH SBIR/STTR award: Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections.
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant2 Apr 2024Publicly observed
NIH SBIR/STTR award: Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections.
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant23 Jun 2023Publicly observed
NIH SBIR/STTR award: Diagnostic tool for assessment and tracking of microbial load in bloodstream infections
USD 996,497.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant20 Jun 2023Publicly observed
NIH SBIR/STTR award: Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant14 Apr 2021Publicly observed
NIH SBIR/STTR award: Direct-from-specimen characterization of bloodstream infections
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant4 Jan 2018Publicly observed
NIH SBIR/STTR award: Direct-from-specimen identification of pathogens common in endocarditis
USD 986,903.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant4 Jan 2018Publicly observed
NIH SBIR/STTR award: Direct-from-specimen identification of pathogens common in endocarditis
USD 1,049,999.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.